6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/3/2025BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...

6/2/2025BeiGene Redomiciles to Switzerland and Transitions to BeOne Medicines

6/2/2025ArkBio's AK3280 Shows Significant Phase II Efficacy in IPF

6/2/2025VelaVigo Expands Global Footprint with Strategic U.S. Biotech Collabor...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/20252025 Outlook for Medtech in China (Simon Kucher)

5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...

5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...

5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...

5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Recent Official and Executive Moves

5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED

5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China

5/29/2025Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...

5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...

5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer

5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China

5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...

Page:2/770 Total number of articles:23089: [First][<<] [1] [2] [3] [4] [5] [>>] [End]